News

Have the clinical signs of a serious type of blood cancer changed?

DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer

The IRP1/ARID3A complex: A novel epigenetic driver of chemoresistance in pancreatic cancer

Cutting-edge drug shows promise for patients with NRAS-driven melanoma

Experimental KRAS vaccine generates immune response against pancreatic cancer in people at high risk

Turning the tables on chemotherapy resistance: LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer

Early inflammation signal drives oral cancer development, highlights path for immunoprevention

Researchers identify immune cell that builds cancer-fighting hubs inside tumours

Tiny molecules, big possibilities: Researchers explore a new way to slow lung cancer

FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer

Cutting-edge drug shows promise for patients with NRAS-driven melanoma

Researchers developing next-generation cancer therapies by switching off cancer’s DNA repair machinery